Dynamics and variegation in the Treg response to Interleukin-2

K Kumba Seddu (Department of Immunology, Harvard Medical School) K Kaitavjeet Chowdhary (Department of Immunology, Harvard Medical School) M Molly Henderson (Department of Immunology, Harvard Medical School) J Jakub Tomala (Department of Chemical and Biomolecular Engineering, Johns Hopkins University) O Odhran Casey (Department of Immunology, Harvard Medical School) Y Yi Cao D Diane Mathis (Department of Immunology, Harvard Medical School) J Jamie B. Spangler C Christophe Benoist (Department of Immunology, Harvard Medical School)

Abstract

Interleukin-2 (IL2) is the key trophic factor for T regulatory (Treg) cells, controlling their differentiation and homeostasis. To understand how temporally regulated responses to IL2 unfold in Tregs, we performed fine time-course analyses, at population and single-cell levels, of changes in chromatin architecture and mRNAs induced by IL2 in Tregs in vivo. The data revealed responses that were largely uniform in rTreg, but diverse among aTregs, matching different STAT5 signal transduction efficiency. Individual Tregs displayed divergences in the preponderance of changes that may be attributed to STAT1 or STAT5 signal transduction downstream of IL2. Chromatin analysis identified an evolving implication of transcription factors that accounted for the waves of responsive genes. Covalent cytokine/Ab complexes that preferentially trigger high- (heterotrimer) or low-affinity (heterodimer) IL2 receptors activated the same signatures, yet with strong quantitative variations, especially in NK cells. Thus, IL2 is not a monolithic activator for Tregs, but a variegated sculptor of Treg identity.

Article Details

Volume / Issue Vol. 122, Issue 47
Published November 25, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (9)

K

Kumba Seddu

Department of Immunology, Harvard Medical School

K

Kaitavjeet Chowdhary

Department of Immunology, Harvard Medical School

M

Molly Henderson

Department of Immunology, Harvard Medical School

J

Jakub Tomala

Department of Chemical and Biomolecular Engineering, Johns Hopkins University

O

Odhran Casey

Department of Immunology, Harvard Medical School

Y

Yi Cao

D

Diane Mathis

Department of Immunology, Harvard Medical School

J

Jamie B. Spangler

C

Christophe Benoist

Department of Immunology, Harvard Medical School